• Drugs for Correcting Water Electrolyte and Acidbase Disturbances, Infant Prem Fortified Feed Lactose Free
    Dosage form: Liquid
    Strength: 20 cal/60ml, 24 cal/60 ml
    Indications/Special comments: For the routine feeding of some prematures infants with feeding problems resulting from sensitivity to milk-based formula.
    Dosage Administration: As tolerated by infant
    View full drug info
  • Drugs for Correcting Water Electrolyte and Acidbase Disturbances, Infant Milk Fortifier Powder
    Dosage form: Sachet
    Strength: n/a
    Indications/Special comments: Nutritional supplement to be added to expressed breast milk for premature or low-birth-weight infants
    Dosage Administration: To 50 ml of breast milk add 1 packet to gain 2 additional calories per fl/oz.To 25ml of breast milk add 1 packet to gain 4 additional calories per fl/oz.
    View full drug info
  • Drugs for Correcting Water Electrolyte and Acidbase Disturbances, Infant Fortified Feed Soya Protein
    Dosage form: Liquid
    Strength: Liquid: 20 cal/120 ml, 20 cal/ 60 ml
    Indications/Special comments: For the routine feeding of some infants with feeding problems resulting from sensitivity to milk-based formula.
    Dosage Administration: As tolerated by infant
    View full drug info
  • Drugs for Correcting Water Electrolyte and Acidbase Disturbances, Infant Fortified Feed Lactose Free
    Dosage form: Liquid
    Strength: 20 cal/120 ml, 20 cal/ 60 ml
    Indications/Special comments: Designed for newborns and infants who are allergic to the intact proteins in cow’s milk and soy formulas, as well as other foods.
    Dosage Administration: As tolerated by infant
    View full drug info
  • Cardiovascular Drugs, Ivabradine Hydrochloride
    Dosage form: Tablet
    Strength: 5mg, 7.5mg
    Indications/Special comments: Treatment of angina in patients in normal sinus rhythm
    Dosage Administration: Treatment of angina in patients in normal sinus rhythm. Adult: Initially, 5mg twice daily for 3 – 4 weeks then increased if necessary to 7.5mg twice daily; reduced if not tolerated to 2.5 – 5mg twice daily, heart rate at rest should not be allowed to fall below 50 beats per minute. Elderly: Initially, 2.5mg twice daily, heart rate at rest should not be allowed to fall below 50 beats per minute.Mild to severe chronic heart failure; Initially, 5mg twice daily for 2 weeks then increased if necessary to 7.5mg twice daily; reduced if not tolerated to 2.5mg twice daily, heart rate at rest should not be allowed to fall below 50 beats per minute
    View full drug info
  • Cardiovascular Drugs, Isosorbide Dinitrate
    Dosage form: Tablet (sublingual)
    Strength: 10mg
    Indications/Special comments: Relief of acute anginal attacks and for management of long-term angina pectoris; congestive cardiac failure.
    Dosage Administration: Adult: Sublingually: Angina (acute attack): 2.5 - 10mg, if relief is not attained after a single dose, additional doses may be given at 5 - 10 minute intervals; no more than 3 doses should be given in a 15 - 30 minute period. Angina prophylaxis: 2.5 - 10mg 4 - 6 hourly. Congestive cardiac failure: 40mg four times daily. However, as 6 hourly administrations may promote tolerance, 12 hourly dosage is preferable, alternatively dosing with a nitrate-free night restores tolerance.
    View full drug info
  • Cardiovascular Drugs, Isoprenaline Hydrochloride
    Dosage form: Injection
    Strength: 0.2mg/ml
    Indications/Special comments: Severe bradycardia, unresponsive to atropine; short-term emergency treatment of heart block; ventricular arrhythmias secondary to atrioventricular nodal block.
    Dosage Administration: Adult: Emergency treatment: Slow IV bolus: 0.01 - 0.06mg (10 - 60mcg), with subsequent doses ranging from 0.01 - 0.2mg. IV infusion: initially 1 mcg/minute, adjusted according to response. Child: IM or SC: 0.2mg as a single dose. IV: 0.02mg as a single dose. IV infusion: 0.2mg (1ml) in 200ml 5% dextrose water; rate depends on size of patient and situation.
    View full drug info
  • Cardiovascular Drugs, Irbersartan + Hydrochlorothiazide
    Dosage form: Tablet
    Strength: 150+12.5mg; 300+12.5mg
    Indications/Special comments: Treatment of hypertension. May be used in patients whose blood pressure is not adequately controlled on monotherapy. Patients with stage 2 (moderate or severe) hypertension are at relatively high risk for cardiovascular events (such as strokes, heart attacks, and heart failure), kidney failure, and vision problems, so prompt treatment is clinically relevant.
    Dosage Administration: Initial therapy: Hydrochlorothiazide 12.5mg - Irbesartan 150mg orally once a day; may increase after 1 to 2 weeks. Add-on/Replacement therapy: Hydrochlorothiazide 12.5 to 25mg - Irbesartan 150 to 300mg orally once a day.Maximum dose: Hydrochlorothiazide 25mg - Irbesartan 300mg orally
    View full drug info
  • Cardiovascular Drugs, Irbersartan
    Dosage form: Tablet
    Strength: 150+12.5mg; 300+12.5mg
    Indications/Special comments: Hypertension in patients receiving haemodialysis. Renal disease in hypertensive type 2 diabetes mellitus. Adult 18 – 74 years: Renal disease in hypertensive type 2 diabetes mellitus in patients receiving haemodialysis.
    Dosage Administration: Hypertension- By mouth: Adult 18 – 74 years: Initially, 150mg once daily, increased if necessary to 300mg once daily. Adult 75 years and over: Initially, 75 – 150mg once daily, increased if necessary to 300mg once daily. Hypertension in patients receiving haemodialysis: Adult: Initially, 75 – 150mg once daily, increased if necessary to 300mg once daily. Renal disease in hypertensive type 2 diabetes mellitus- Adult 18 –74 years: Initially, 150mg once daily, increased if tolerated to 300 mg once daily. Adult 75 years and over: Initially, 75 – 150mg once daily, increased if tolerated to 300mg once daily. Renal disease in hypertensive type 2 diabetes mellitus in patients receiving haemodialysis- Adult: Initially, 75 – 150mg once daily, increased if tolerated to 300mg once daily.
    View full drug info
  • Cardiovascular Drugs, Indapamide
    Dosage form: Tablet
    Strength: 1.5 mg SR
    Indications/Special comments: Mild to moderate hypertension. Oedema associated with HF and other causes
    Dosage Administration: Adults: Hypertension– 1.25 – 5mg once daily in the morning; may be increase at 4-wk intervals up to 5mg/day. Oedema secondary to HF– 2.5mg once daily in the morning; may be increase after 1 wk to 5mg/day.
    View full drug info